53 related articles for article (PubMed ID: 21355420)
1. Exploring the binding affinities of p300 enzyme activators CTPB and CTB using docking method.
Devipriya B; Parameswari AR; Rajalakshmi G; Palvannan T; Kumaradhas P
Indian J Biochem Biophys; 2010 Dec; 47(6):364-9. PubMed ID: 21355420
[TBL] [Abstract][Full Text] [Related]
2. Investigation of activation mechanism and conformational stability of
Sivanandam M; Manjula S; Kumaradhas P
J Biomol Struct Dyn; 2019 Sep; 37(15):4006-4018. PubMed ID: 30301423
[TBL] [Abstract][Full Text] [Related]
3. Charge density distribution and the electrostatic moments of CTPB in the active site of p300 enzyme: a DFT and charge density study.
Devipriya B; Kumaradhas P
J Theor Biol; 2013 Oct; 335():119-29. PubMed ID: 23770402
[TBL] [Abstract][Full Text] [Related]
4. Activation of p300 histone acetyltransferase by small molecules altering enzyme structure: probed by surface-enhanced Raman spectroscopy.
Mantelingu K; Kishore AH; Balasubramanyam K; Kumar GV; Altaf M; Swamy SN; Selvi R; Das C; Narayana C; Rangappa KS; Kundu TK
J Phys Chem B; 2007 May; 111(17):4527-34. PubMed ID: 17417897
[TBL] [Abstract][Full Text] [Related]
5. A Small Molecule Activator of p300/CBP Histone Acetyltransferase Promotes Survival and Neurite Growth in a Cellular Model of Parkinson's Disease.
Hegarty SV; O'Leary E; Solger F; Stanicka J; Sullivan AM; O'Keeffe GW
Neurotox Res; 2016 Oct; 30(3):510-20. PubMed ID: 27256286
[TBL] [Abstract][Full Text] [Related]
6. Small molecule modulators of histone acetyltransferase p300.
Balasubramanyam K; Swaminathan V; Ranganathan A; Kundu TK
J Biol Chem; 2003 May; 278(21):19134-40. PubMed ID: 12624111
[TBL] [Abstract][Full Text] [Related]
7. Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation.
Aikawa Y; Nguyen LA; Isono K; Takakura N; Tagata Y; Schmitz ML; Koseki H; Kitabayashi I
EMBO J; 2006 Sep; 25(17):3955-65. PubMed ID: 16917507
[TBL] [Abstract][Full Text] [Related]
8. Probing the effect of intermolecular interaction and understanding the electrostatic moments of anacardic acid in the active site of p300 enzyme via DFT and charge density analysis.
Devipriya B; Kumaradhas P
J Mol Graph Model; 2012 Apr; 34():57-66. PubMed ID: 22306413
[TBL] [Abstract][Full Text] [Related]
9. Differential recognition of phosphorylated transactivation domains of p53 by different p300 domains.
Polley S; Guha S; Roy NS; Kar S; Sakaguchi K; Chuman Y; Swaminathan V; Kundu T; Roy S
J Mol Biol; 2008 Feb; 376(1):8-12. PubMed ID: 18155245
[TBL] [Abstract][Full Text] [Related]
10. Autoacetylation induced specific structural changes in histone acetyltransferase domain of p300: probed by surface enhanced Raman spectroscopy.
Arif M; Kumar GV; Narayana C; Kundu TK
J Phys Chem B; 2007 Oct; 111(41):11877-9. PubMed ID: 17894486
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of p300 specific histone acetyltransferase inhibition by small molecules.
Arif M; Pradhan SK; Thanuja GR; Vedamurthy BM; Agrawal S; Dasgupta D; Kundu TK
J Med Chem; 2009 Jan; 52(2):267-77. PubMed ID: 19086895
[TBL] [Abstract][Full Text] [Related]
12. Binding mechanism of spinosine and venenatine molecules with p300 HAT enzyme: Molecular screening, molecular dynamics and free-energy analysis.
Magudeeswaran S; Poomani K
J Cell Biochem; 2020 Feb; 121(2):1759-1777. PubMed ID: 31633226
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region.
Somasundaram K; El-Deiry WS
Oncogene; 1997 Mar; 14(9):1047-57. PubMed ID: 9070653
[TBL] [Abstract][Full Text] [Related]
14. Interactions with p300 enhance transcriptional activation by the PDZ-domain coactivator Bridge-1.
Lee JH; Volinic JL; Banz C; Yao KM; Thomas MK
J Endocrinol; 2005 Nov; 187(2):283-92. PubMed ID: 16293776
[TBL] [Abstract][Full Text] [Related]
15. The N-terminal transactivation domain of ATF2 is a target for the co-operative activation of the c-jun promoter by p300 and 12S E1A.
Duyndam MC; van Dam H; Smits PH; Verlaan M; van der Eb AJ; Zantema A
Oncogene; 1999 Apr; 18(14):2311-21. PubMed ID: 10327051
[TBL] [Abstract][Full Text] [Related]
16. Schistosoma mansoni CBP/p300 has a conserved domain structure and interacts functionally with the nuclear receptor SmFtz-F1.
Bertin B; Oger F; Cornette J; Caby S; Noël C; Capron M; Fantappie MR; Rumjanek FD; Pierce RJ
Mol Biochem Parasitol; 2006 Apr; 146(2):180-91. PubMed ID: 16427147
[TBL] [Abstract][Full Text] [Related]
17. Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP.
Lundblad JR; Kwok RP; Laurance ME; Harter ML; Goodman RH
Nature; 1995 Mar; 374(6517):85-8. PubMed ID: 7870179
[TBL] [Abstract][Full Text] [Related]
18. Role of plant CBP/p300-like genes in the regulation of flowering time.
Han SK; Song JD; Noh YS; Noh B
Plant J; 2007 Jan; 49(1):103-14. PubMed ID: 17144897
[TBL] [Abstract][Full Text] [Related]
19. Development of Selective CBP/P300 Benzoxazepine Bromodomain Inhibitors.
Popp TA; Tallant C; Rogers C; Fedorov O; Brennan PE; Müller S; Knapp S; Bracher F
J Med Chem; 2016 Oct; 59(19):8889-8912. PubMed ID: 27673482
[TBL] [Abstract][Full Text] [Related]
20. Investigation of intermolecular interactions and binding mechanism of PU139 and PU141 molecules with p300 HAT enzyme via molecular docking, molecular dynamics simulations and binding free energy analysis.
Ramakrishnan J; Magudeeswaran S; Suresh S; Poomani K
J Biomol Struct Dyn; 2023 Mar; 41(4):1351-1365. PubMed ID: 34974819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
